Literature DB >> 34328696

Comparison of Patient-Reported Outcomes Measurement Information System Computerized Adaptive Testing Versus Fixed Short Forms in Juvenile Myositis.

Ruchi N Patel1, Valeria G Esparza2, Jin-Shei Lai1, Elizabeth L Gray1, Bryce B Reeve3, Rowland W Chang1, David Cella1, Kaveh Ardalan4.   

Abstract

OBJECTIVE: Patient-Reported Outcomes Measurement Information System (PROMIS) measures can be administered via computerized adaptive testing (CAT) or fixed short forms (FSFs), but the empirical benefits of CAT versus FSFs are unknown in juvenile myositis (JM). The present study was undertaken to assess whether PROMIS CAT is feasible, precise, correlated with FSFs, and less prone to respondent burden and floor/ceiling effects than FSFs in JM.
METHODS: Patients 8-17 years of age (self-report and parent proxy) and parents of patients 5-7 years of age (only parent proxy) completed PROMIS fatigue, pain interference, upper extremity function, mobility, anxiety, and depressive symptoms measures. Pearson correlations, paired t-tests, and Cohen's d were calculated between PROMIS CAT and FSFs. McNemar's test assessed floor/ceiling effects between CAT and FSFs. Precision and respondent burden were examined across the T score range.
RESULTS: Data from 67 patient-parent dyads were analyzed. CAT and FSF mean scores did not significantly differ except in parent proxy anxiety and fatigue (effect size 0.23 and 0.19, respectively). CAT had less pronounced floor/ceiling effects at the less symptomatic extreme in all domains except self-report anxiety. Increased item burden and higher SEs were seen in less symptomatic scorers for CAT. Modified stopping rules limiting CAT item administration did not decrease precision.
CONCLUSION: PROMIS CAT appears to be feasible and correlated with FSFs. CAT had less pronounced floor/ceiling effects, allowing detection of individual differences in less symptomatic patients. Modified stopping rules for CAT may decrease respondent burden. CAT can be considered for long-term follow-up of JM patients.
© 2021 American College of Rheumatology.

Entities:  

Year:  2021        PMID: 34328696      PMCID: PMC8800940          DOI: 10.1002/acr.24760

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   5.178


  39 in total

1.  Validation of the Childhood Health Assessment Questionnaire in the juvenile idiopathic myopathies. Juvenile Dermatomyositis Disease Activity Collaborative Study Group.

Authors:  A M Huber; J E Hicks; P A Lachenbruch; M D Perez; L S Zemel; R M Rennebohm; C A Wallace; C B Lindsley; M H Passo; S H Ballinger; S L Bowyer; A M Reed; P H White; I M Katona; F W Miller; L G Rider; B M Feldman
Journal:  J Rheumatol       Date:  2001-05       Impact factor: 4.666

2.  A New Stopping Rule for Computerized Adaptive Testing.

Authors:  Seung W Choi; Matthew W Grady; Barbara G Dodd
Journal:  Educ Psychol Meas       Date:  2010-12-01       Impact factor: 2.821

3.  Sampling plan and patient characteristics of the PROMIS pediatrics large-scale survey.

Authors:  Debra E Irwin; Brian D Stucky; David Thissen; Esi Morgan Dewitt; Jin Shei Lai; Karin Yeatts; James W Varni; Darren A DeWalt
Journal:  Qual Life Res       Date:  2010-03-05       Impact factor: 4.147

4.  The PedsQL in pediatric rheumatology: reliability, validity, and responsiveness of the Pediatric Quality of Life Inventory Generic Core Scales and Rheumatology Module.

Authors:  James W Varni; Michael Seid; Tara Smith Knight; Tasha Burwinkle; Joy Brown; Ilona S Szer
Journal:  Arthritis Rheum       Date:  2002-03

5.  Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients.

Authors:  Angelo Ravelli; Lucia Trail; Cristina Ferrari; Nicolino Ruperto; Angela Pistorio; Clarissa Pilkington; Susan Maillard; Sheila K Oliveira; Flavio Sztajnbok; Ruben Cuttica; Matilde Beltramelli; Fabrizia Corona; Maria Martha Katsicas; Ricardo Russo; Virginia Ferriani; Ruben Burgos-Vargas; Silvia Magni-Manzoni; Eunice Solis-Valleoj; Marcia Bandeira; Francesco Zulian; Vicente Baca; Elisabetta Cortis; Fernanda Falcini; Maria Alessio; Maria Giannina Alpigiani; Valeria Gerloni; Claudia Saad-Magalhaes; Rosanna Podda; Clovis A Silva; Loredana Lepore; Enrico Felici; Federica Rossi; Elena Sala; Alberto Martini
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-01-15       Impact factor: 4.794

6.  Level of agreement between children, parents, and physicians in rating pain intensity in juvenile idiopathic arthritis.

Authors:  Pablo Garcia-Munitis; Marcia Bandeira; Angela Pistorio; Silvia Magni-Manzoni; Nicolino Ruperto; Ambra Schivo; Alberto Martini; Angelo Ravelli
Journal:  Arthritis Rheum       Date:  2006-04-15

7.  Clinical characteristics of children with juvenile dermatomyositis: the Childhood Arthritis and Rheumatology Research Alliance Registry.

Authors:  Angela Byun Robinson; Mark F Hoeltzel; Dawn M Wahezi; Mara L Becker; Elizabeth A Kessler; Heinrike Schmeling; Ruy Carrasco; Adam M Huber; Brian M Feldman; Ann M Reed
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-03       Impact factor: 4.794

8.  Psychometric properties of the PROMIS ® pediatric scales: precision, stability, and comparison of different scoring and administration options.

Authors:  James W Varni; Brooke Magnus; Brian D Stucky; Yang Liu; Hally Quinn; David Thissen; Heather E Gross; I-Chan Huang; Darren A DeWalt
Journal:  Qual Life Res       Date:  2013-10-02       Impact factor: 4.147

Review 9.  The future of measuring patient-reported outcomes in rheumatology: Patient-Reported Outcomes Measurement Information System (PROMIS).

Authors:  Dinesh Khanna; Eswar Krishnan; Esi Morgan Dewitt; Puja P Khanna; Brennan Spiegel; Ron D Hays
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-11       Impact factor: 4.794

10.  Comparing the importance of quality measurement themes in juvenile idiopathic inflammatory myositis between patients and families and healthcare professionals.

Authors:  Heather O Tory; Ruy Carrasco; Thomas Griffin; Adam M Huber; Philip Kahn; Angela Byun Robinson; David Zurakowski; Susan Kim
Journal:  Pediatr Rheumatol Online J       Date:  2018-04-19       Impact factor: 3.054

View more
  1 in total

1.  Calibration of the Dutch EyeQ to Measure Vision Related Quality of Life in Patients With Exudative Retinal Diseases.

Authors:  T Petra Rausch-Koster; Michiel A J Luijten; F D Verbraak; Ger H M B van Rens; Ruth M A van Nispen
Journal:  Transl Vis Sci Technol       Date:  2022-04-01       Impact factor: 3.283

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.